Clinical Trials Sponsored by Beneo-Institute

Total 74736 results

National Cancer Institute (NCI)

Completed

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

Sarcoma | Lymphoma | Neuroblastoma | WilmsTumor

United States
National Cancer Institute (NCI)

Withdrawn

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

Sarcoma | Lymphoma | Brain Neoplasms | Osteosarcoma | Wilm's Tumor

United States
National Eye Institute (NEI)

Completed

Genetic Study of Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Eye Institute (NEI)

Completed

Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema

Diabetic Retinopathy

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation

Cancer

United States
National Eye Institute (NEI)

Completed

Screening for Studies on Inherited Eye Diseases

Hereditary Eye Disease

United States
National Cancer Institute (NCI)

Completed

Natural History Study of Moles and Suspicious Melanoma

Melanocytic Nevi | Acquired Melanocytic Nevi | Primary Cutaneous Melanoma

United States
National Eye Institute (NEI)

Completed

Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa

Retinitis Pigmentosa

United States
National Eye Institute (NEI)

Completed

Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis

Uveitis

United States
National Eye Institute (NEI)

Completed

Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

Cancer | Mortality | Uveitis | Infection | Immunosuppression

United States
National Eye Institute (NEI)

Completed

Identification and Treatment of Feeder Vessels in Macular Degeneration

Macular Degeneration

United States
National Eye Institute (NEI)

Completed

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Von Hippel-Lindau Syndrome

United States
National Cancer Institute (NCI)

Completed

Specimens From Normal Controls

Viral Infections

United States
National Eye Institute (NEI)

Completed

Evaluation and Treatment of Patients With Retinal Disease

Retinal Disease

United States
National Eye Institute (NEI)

Completed

Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection

Blastomycosis

United States
National Eye Institute (NEI)

Completed

Dynamic Light Scattering to Study Crystalline Proteins in Young Normal Lenses

Healthy

United States
National Cancer Institute (NCI)

Completed

Late Effects of Treatment for Sarcomas in Children

Sarcoma

United States
National Cancer Institute (NCI)

Completed

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

Sarcoma

United States
National Cancer Institute (NCI)

Terminated

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Epithelial Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

Cutaneous T Cell Lymphoma | Peripheral T Cell Lymphoma

United States, Australia
National Cancer Institute (NCI)

Completed

Phase II ABT-888 With Cyclophosphamide

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Triple-Negative Breast Cancer | Serous Carcinoma Cancer

United States, Canada
National Cancer Institute (NCI)

Terminated

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Brain and Central Nervous System Tumors

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Ponatinib for Advanced Medullary Thyroid Cancer

Thyroid Neoplasms

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Liver Cancer

United States
National Cancer Institute (NCI)

Completed

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Urothelial Carcinoma | Ureteral Neoplasms | Ureter Cancer | Cancer of the Ureter | Neoplasm, Ureteral

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Sarcoma | Kidney Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Melanoma (Skin)

United States
National Institutes of Health (NIH)

Completed

Bio-behavioral Lung Cancer Prevention Program

Smoking Cessation

United States
National Cancer Institute (NCI)

Terminated

Imaging Studies of Kidney Cancer Using 18F-VM4-037

Kidney Neoplasms | Carcinoma, Renal Cell

United States
National Cancer Institute (NCI)

Completed

153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Thymic Carcinoma | Thymoma | Thymic Carcinoid | Thymic Neuroendocrine Tumors

United States
National Eye Institute (NEI)

Completed

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration (AMDB1)

Age-Related Macular Degeneration | Choroidal Neovascularization

United States
National Eye Institute (NEI)

Completed

CNTF Implants for CNGB3 Achromatopsia (CNTF-CNGB3-1)

Eye Disease | Achromatopsia

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy

Lymphoma

United States
National Cancer Institute (NCI)

Completed

B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency

IgA Deficiency

United States
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)

Terminated

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma

Metastatic Cancer | Metastatic Melanoma

United States
Indiana University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Breathe for Hot Flashes Randomized Controlled Trial

Hot Flashes

United States
National Cancer Institute (NCI)

Completed

Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia

Lymphoma, Non-Hodgkin | Hodgkin's Disease

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes

Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Completed

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Glioblastoma | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Mixed Oligoastrocytoma

United States
National Cancer Institute (NCI)

Terminated

MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes

Metastatic Cancer | Metastatic Melanoma | Metastatic Renal Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Terminated

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Skin Cancer | Metastatic Melanoma

United States
National Cancer Institute (NCI)

Terminated

Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

Metastatic Cancer

United States
National Cancer Institute (NCI)

Terminated

Vandetanib to Treat Advanced Kidney Cancer

Advanced Clear Cell Renal Carcinoma

United States
National Cancer Institute (NCI)

Completed

A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)

NSCLC | Solid Tumors

United States
Professor Fernando Figueira Integral Medicine Institute
Instituto Nacional de Cancer, Brazil

Completed

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients

Cancer of Cervix

Brazil
National Cancer Institute (NCI)

Terminated

Sunitinib to Treat Recurrent Brain Cancer

Glioblastoma Multiforme | Malignant Gliomas | Anaplastic Gliomas

United States
National Polytechnic Institute, Mexico
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

Allergic Rhinoconjunctivitis

Clinical Trials Sponsored by Beneo-Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations